Introduction
Aminopeptidase N (APN) is a member of a family of proteins known as ectoenzymes. These enzymes comprise a diverse group of hydrolases broadly divided into peptidases, phosphatases, and glycosidases (for review see Kenny and Turner, 1987) . The active site of these enzymes is exposed at the cell surface and they therefore act to hydrolyze substrates in the extracellular space. The function of the ectoenzymes, however, still remains largely unknown.
APN belongs to the group of ectoenzymes known as cell surface peptidases. It is likely that the functions of these peptidases vary according to their cellular location. In the intestine they are believed to be involved in the final stages of digestion , but it is possible that in other locations they may have a role in the inactivation of signaling peptides. It has also been suggested that the presence of a battery of ectoenzymes within an organ system may modulate the activity of peptide hormones and growth factors and regulate their access to target cells (Kenny et al., 1989) .
A number of ectoenzymes have previously been demonstrated in the human breast. These include alkaline phosphatase (Newman et al., 1950) and neutral endopeptidase-24.11 (NEP), otherwise known as CAUA (Letarte et al., 1988; Greaves et al., 1975) both of which are specific markers of myoepithelial cells (Gusterson et al., 1986) . Ecto-5'-nucleotide has recently been shown to be present on fibroblasts and epithelium (Kmgger et al., 1991) . Recent experiments in our laboratory have demonstrated the expression of dipeptidyl peptidase IV (DPP IV), another cell surface peptidase, on a subpopulation of fibroblasts within the breast.
Interlobular fibroblasts are DPP IV positive, whereas intralobular fibroblasts are DPP IV negative (Atherton et al., in press ). This specificity is maintained in tumors that are known to be derived from intralobular fibroblasts. These observations support the view that these enzymes are functional phenotypic markers for defined cell types.
The present study describes the light microscopic and ultrastructural localization of a further member of the ectoenzyme family, aminopeptidase N (APN), in the human breast.
Materials and Methods
Antibodies. Five antibodies recognizing APN were used in this study. These included four mouse monoclonal antibodies (MAb): CLB-mon-gran/Z (IgG2,; Janssen Biochimica, Beerse, Belgium), MY7 (IgG1; Coulter Immunology, Hialeah, FL), RMAG6 (IgGl) of women aged 18-30 years), eight carcinomas, nine fibroadenomas. and two phyllodes tumors were examined.
Frozen sections ( 5 pm) were cut on a cryostat. air-dried overnight. and fixed in chloroform:acctonc (50:50, vlv) at -20% for 5 min before staining using an indirect immunopcroxidasc technique. Endogenous pcroxidase was blocked in 0.1% phenylhydrazine hydrochloride in PBS at room temperature for 5 min. After rinsing in PBS (three times for 5 min) the sections were incubated for 1 hr with 100 pl of CLB-mon-gran12 diluted 1:lOOO in 0.5% bovine serum albumin in PBS (BSAIPBS). After three further 5-min washes in PBS the sections wcrc incubated with 100 VI of rabbit anti-mouse peroxidase conjugate (Dako: High Wycombe, UK) diluted 1:lOO in BSAIPBS. After 1 hr the sections were washed and developed for 5 min at room temperature using 100 mg 3,3'-diaminobenzidinc tctrahydrochloride (Sigma; Poole, UK) dissolved in 100 ml Tris-HCI (0.1 M. pH 7.2). 100 _ - Figure 2 . An immunolabeled cryosection of human breast. APN is demonstrated on the surface of fibroblasts (F) and their attenuated cell processes (arrow). The myoepithelial cells (M) and associated basement membrane do not express APN. Bar = 1 um. ml distilled water, and 66 p1 hydrogen peroxide. Sections were counterstained in Mayer's hematoxylin and mounted in DePex. Control sections were stained in the absence of the primary antibody and were all negative.
Tissue Promsing and Immunocytochemistry for Electron Microscopy. Samples of normal breast tissue up to 0.5 mm3 were fixed in 2% paraformaldehyde plus 0.05% glutaraldehyde in PBS for 1 hr at room temperature. After rinsing in PBS (three times for 5 min) the tissue was cryoprotectcd in 2.3 M sucrose in PBS at 4'C overnight. The samples were frozen in liquid nitrogen, transferred to a Rcichcrt Ultracut ElFC4 cryoultramicrotome. and sectioned at 80 nm. The sections were collected on gold grids coated with carbon on formvar and stored on 2 % gelatin in PBS at 4'C for no more than 5 days. After two 5-min washes, nonspecific staining was blocked with 5 % fetal calf serum (FCS) in PBS (FCSIPBS) at room temperature for 15 min. Sections were then incubated overnight in CLB-mon-granl2 diluted 1:500 in FCSIPBS. After three further 5-min washes in PBS, the sections were incubated in goat anti-mouse antibody conjugated to 1-nm colloidal gold (Amenham International; High Wycombe, UK) diluted 1:50 in FCSlPBS for 1.5 hr. This was followed by three washes in ultra-high-qualitywater (UHQ; ELGA, High Wycombe, UK) for a total of 15 min. The colloidal gold was silver-enhanced for 10 min with Intense M (Amersham). Control sections were incubated either in the absence of primary antibody or with an alternative primary MAb of the same subclass (IgGa).
The cryosections were contrasted and embedded in 2% methyl cellulose (25cp; Aldrich Chemical Company, Dorset, UK) containing 3% uranyl acetate (wlv in UHQ) (Monaghan and Atherton, in press ). Sections were then viewed in a Philips CMlO electron microscope.
Results

Light Microscopy
In the normal human breast APN was localized to cells within the inter-and intralobular stroma and in luminal epithelial cells (Figures la and Ib). This epithelial staining was restricted to the apical region of the cells. Although the myoepithelial cells appeared APN negative by light microscopy, it was not possible to determine the localization of the strong APN staining surrounding the lobules. Furthermore, at the light microscopic level it was unclear whether capillary endothelial cells expressed APN. Ultrastructural localization of APN was therefore necessary to identify the precise cellular distribution of this enzyme.
In the breast carcinomas some tumor cells and the majority of their associated stromal cells were positive. The distribution of APN in the fibroadenomas and phyllodes tumors was similar to that seen in the normal tissue.
Electron Microscopy
APN was localized at the ultrastructural level on thawed cryosections. In the stroma of the breast the APN-positive cells were elongated, with long attenuated processes. The ultrastructural characteristics of these cells identified them as fibroblasts. Labeling was restricted to the cell membrane and processes of these fibroblasts, and cytoplasmic labeling was rarely observed (Figures 2 and 3) . The staining, which at the light microscopic level appeared to surround the acini of the lobules, was cle,arly associated with the fibroblasts that delineate these acini. The basement membrane and associated myoepithelial cells did not express the enzyme (Figure 2) . Endothelial cells of capillaries and small vessels were APN negative in both the inter-and intralobular stroma (Figure 3 ).
The enzyme was further localized to the apical membrane and the cytoplasm of some epithelial cells (Figure 4) . This cytoplasmic localization was generally associated with membrane-bound vesicles. In some acini the luminal epithelial cells were either all APN positive or all APN negative. whereas other acini contained both positive and negative luminal epithelial cells (Figure 4) .
Control sections labeled in the absence of primary antibody were negative, and those incubated with an alternative primary antibody showed a different labeling pattern.
Discussion
The distribution of the ectoenzyme APN was demonstrated in the human breast at the light microscopic and the ultrastructural level. Within the epithelial component of the breast, APN expression was restricted to the apical region of a proportion of luminal epithelial cells. In the stromal compartment of the breast this enzyme was detected on the plasma membrane of both inter-and intralobular fibroblasts. This pattern of expression was maintained in benign and malignant tumors. The light microscopic distribution of APN indicated its presence on the majority of stromal cells. However, the ultrastructural localization of the enzyme demonstrated that its expression was restricted to fibroblasts, whereas the myoepithelial cells and associated basement membrane were APN negative. Furthermore, the enzyme was not detected on endothelial cells of capillaries and small vessels.
These observations, taken together with the distribution of other ectoenzymes in the breast, raise interesting questions concerning the potential role of these enzymes in the local control of growth and differentiation (Kenny et al., 1989) . In contrast to the pattern of APN expression described in this study, the ectoenzyme DPP IV is restricted to a subpopulation of fibroblasts in the human breast.
DPP IV is present only on interlobular fibroblasts, whereas intralobular fibroblasts do not express detectable levels of this enzyme. Capillary endothelial cells have also been shown to express DPP IV (Atherton et al., in press ).
The different ectoenzymes are known to have specificities for certain amino acid sequences but, with the exception of NEP, little is known of their function either in vivo or in vitro. NEP is specific for myoepithelial cells in the human breast (Gusterson et al., 1986) . an observation that may correlate with the demonstration that oxytocin is a potential substrate for NEP . This enzyme has been localized by ultrastructural immunocytochemistry (Gusterson et al.. 1986 ) and has been shown to be present on all myoepithelial cell membranes, with the exception of the portion of the cell adjacent to the basement membrane. The striking distribution of this enzyme in the breast may indicate a role for NEP in modulating cell-cell contacts or paracrine factors. Clearly, to elucidate the in vivo function of these ectoenzymes it is vital to define the cell types that express each enzyme.
The significance of the presence of APN on breast fibroblasts and some luminal epithelial cells is unclear. APN catalyzes the removal of N-terminal amino acid residues from peptides, with a preference for neutral residues (McDonald and Barrett, 1986) . Its role in vivo, like that ofother ectoenzymes. is unknown. In vitro it has been suggested that APN, like NEP, is involved in the hydrolysis of enkephalins (Bowes and Kenny, 1987) . In the hemapoetic system APN, which has been shown to be identical to CD13 (Look et al., 1989) . is expressed on the cell membranes of granulocytes and monocytes. It is probable, however, that the function of APNICD13 differs in different sites and that extrapolation of data from one cell type to another should be undertaken with caution.
To assess the possible functions of these enzymes in the breast it is necessary to establish assay systems. These will involve organ culture systems in which the role of the enzymes can be considered in intact tissue and in isolated cell preparations. Our ability to maintain proliferating microdissected human breast lobules in organ culture will enable us to use known enzyme inhibitors (Kenny and Hooper, 1991) to assay for functional activity. Fluorescence-activated cell sorting (FACS) has recently been used, in conjunction with antibodies to NEP, to obtain pure populations of myoepithelial cells for functional studies . These methods can similarly be applied to the stromal cells.
The differences in distribution between APN and DPP IV allow an immunological distinction to be made between the three major cellular components of the human breast stroma: endothelial cells (APN -ve / DPP IV +ve), interlobularfibroblasts (APN +ve / DPP IV +ve), and intralobular fibroblasts (APN +ve / DPP IV -ve). Antibodies recognizing these two enzymes are therefore ideal reagents for FACS isolation of defined populations of breast stromal cells for functional studies, which are currently in progress.
